Clinical Trials Directory

Trials / Conditions / Recurrent Laryngeal Verrucous Carcinoma

Recurrent Laryngeal Verrucous Carcinoma

7 registered clinical trials studyying Recurrent Laryngeal Verrucous Carcinoma.

StatusTrialSponsorPhase
TerminatedInterstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer
NCT02068157
Roswell Park Cancer InstitutePhase 2
TerminatedCisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Ne
NCT02196168
National Cancer Institute (NCI)Phase 2
CompletedLenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
NCT01254617
National Cancer Institute (NCI)Phase 1
CompletedTemsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who D
NCT01256385
National Cancer Institute (NCI)Phase 2
CompletedSoy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer
NCT02007200
National Cancer Institute (NCI)Phase 2
Active Not RecruitingChemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squam
NCT00588770
National Cancer Institute (NCI)Phase 3
CompletedCediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
NCT00458978
National Cancer Institute (NCI)Phase 2